Nutrafol Appears in 54.7% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Hair Loss Treatments. For more detail, you can also read Hair Loss Treatments: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- Nutrafol appeared in 395 of 722 benchmark answers, with 274 recommendations and 203 top-three placements.
- The brand ranks third behind Rogaine and Hims, but it is more often shortlisted than chosen first.
- No conflicting claims were recorded in the captured answers, so the first priority is verification and baseline tracking.
- The strongest content opportunities are comparison pages and buyer questions about Nutrafol versus Rogaine and Keeps.
Answer Capsule
In November 2026, Nutrafol appeared in 395 of 722 AI answers included in the Hair Loss Treatments benchmark (54.71%). It received 274 recommendations (37.95%), with 203 Top 3 placements and 30 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Nutrafol mentions, recommendations and placements compare with its Hair Loss Treatments peers?
Nutrafol recorded 395 mentions (54.71%) and 274 recommendations (37.95%) across 722 answers included in the benchmark. Top 3 placements numbered 203; first-place recommendations numbered 30. Framing among its mentions was 296 positive, 94 neutral and 5 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Rogaine | 547 | 75.76% | 341 | 47.23% | 269 | 37.26% | 227 | 31.44% |
2 | Hims | 534 | 73.96% | 322 | 44.60% | 262 | 36.29% | 124 | 17.17% |
3 | Nutrafol | 395 | 54.71% | 274 | 37.95% | 203 | 28.12% | 30 | 4.16% |
4 | Happy Head | 220 | 30.47% | 156 | 21.61% | 122 | 16.90% | 10 | 1.39% |
5 | Keeps | 239 | 33.10% | 125 | 17.31% | 88 | 12.19% | 14 | 1.94% |
6 | Propecia (Merck) | 302 | 41.83% | 105 | 14.54% | 80 | 11.08% | 24 | 3.32% |
7 | Ro | 163 | 22.58% | 77 | 10.66% | 55 | 7.62% | 14 | 1.94% |
8 | Bosley | 56 | 7.76% | 11 | 1.52% | 6 | 0.83% | 2 | 0.28% |
9 | HairClub | 40 | 5.54% | 3 | 0.42% | 2 | 0.28% | 0 | 0.00% |
10 | Folexin | 2 | 0.28% | 2 | 0.28% | 2 | 0.28% | 1 | 0.14% |
Nutrafol sits third in this benchmark, with a strong share of answers mentioning it and a solid share recommending it. The gap to the two leaders is real but not vast, and the brand is clearly part of the conversation. The more striking pattern is placement: Nutrafol appears in many shortlists but rarely takes first place. That suggests the brand is treated as a credible option rather than the default answer.
For the client, the practical question is less about raw presence and more about why answers stop short of leading with Nutrafol. We would build a scorecard that separates reach, endorsement and placement so the team can see which lever matters most. We would also flag that these figures come from a newly broadened question set, so they are a starting point rather than a trend.
What changed since last month
Questions This Section Answers
- How did Nutrafol counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 395 / 722 (54.71%) |
Recommendations | 274 / 722 (37.95%) |
Top 3 recommendations | 203 / 722 (28.12%) |
#1 recommendations | 30 / 722 (4.16%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first on the wider question set, so the monthly figures should be read as a fresh baseline rather than a movement from earlier months. The earlier, narrower editions are not comparable and are best left in the archive. Any apparent change in totals between editions reflects different question coverage, not a measured shift in how answers treat Nutrafol.
That matters for how the client uses the numbers. We would treat this month as the reference point against which future editions are judged, provided the same screening scope is kept. We would also recommend the client resist drawing conclusions from any single month and instead watch the pattern across several comparable editions before adjusting strategy.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- Nutrafolno changeNov 202637.95%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Nutrafol?
AI answers contained 0 conflicting claims about Nutrafol: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
No conflicting claims about Nutrafol were recorded in the captured answers, which is a useful starting position. It means the immediate task is not firefighting disputed statements but building a disciplined way to catch them if they appear. A visibility comparison against the leading brands would help the client see where Nutrafol is strong and where it is merely present.
We would propose a scoped fact-review register that logs any claim worth checking, with an owner and an evidence requirement for each entry. The register would rank items by how much they could affect buyer perception, not by how often they appear. This keeps fact-checking proportionate and avoids treating every AI statement as an error to correct.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Nutrafol should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
No results are available for this part of the analysis, so there is nothing yet to reconcile between AI answers and the company's own materials. That absence is itself informative: it means consistency work should begin with verification rather than with edits. We would not draft corrections until the entity, date and source behind any claim are confirmed.
Where a topic does surface, we would prepare conditional page briefs that only proceed once approved facts are in hand. Different dates can explain an apparent conflict, so the first step is always to establish what was said and when. Briefs would be held until that check is complete, and any proposed change would rest on current primary-source evidence rather than on an AI answer alone.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Nutrafol?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://rochesterregional.org/hub/hair-loss-treatment-nutrafol | 39 | 38 | 0 |
https://innerbody.com/viviscal-vs-nutrafol | 12 | 12 | 0 |
https://nehair.com/blog/rogaine-vs-nutrafol/ | 11 | 11 | 0 |
https://rennorabeauty.com/blogs/news/nutrafol-alternatives | 11 | 11 | 0 |
https://kilgourmd.com/pages/nutrafol-alternative | 9 | 9 | 0 |
https://scandinavianbiolabs.co.uk/blogs/hair-loss/nutrafol-vs-rogaine | 9 | 9 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages selected for review cluster around comparison and alternative content, which is where buyers often form a view of Nutrafol against rivals. None of these pages carries a conflicting claim in the captured answers, so there is no correction case to pursue. The more useful work is to understand what these pages say and whether their framing matches the company's approved positioning.
We would propose a source review that reads each page directly and records its current content before any request is considered. Where a page is accurate but incomplete, a polite evidence-backed suggestion may be appropriate; where it is already sound, the decision is to leave it alone. A citation does not show that a page shaped an answer, and no publisher is assumed to be at fault.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Nutrafol website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://nutrafol.com/ | 4 | 4 | 2 |
https://nutrafol.com/blog/nutrafol-vs-minoxidil/ | 4 | 4 | 2 |
https://nutrafol.com/hair/brand/learn/science/clinical-studies/ | 3 | 3 | 2 |
https://nutrafol.com/blog/nutrafol-vs-hers-comparing-two-approaches-to-hair-growth/ | 2 | 2 | 1 |
https://nutrafol.com/men/ | 2 | 2 | 1 |
https://nutrafol.com/our/brand/about/press/peerclinicalstudy2026/ | 2 | 2 | 2 |
https://help.nutrafol.com/hc/en-us/articles/28788996283283-Should-I-take-Nutrafol-Women-s-Balance-if-I-am-not-in-menopause | 1 | 1 | 0 |
https://nutrafol.com/blog/are-nutrafol-hair-growth-supplements-worth-it-an-honest-look-at-cost-results-and-value/ | 1 | 1 | 1 |
The company's website was cited 27 times across 16 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The company's own pages are cited far less often than third-party sources, which points to an opportunity in owned content rather than a problem to fix. The pages that do appear are mostly comparison and science-led pieces, suggesting answers reward content that directly addresses how Nutrafol stacks up and what supports its claims. The help-centre article on Women's Balance is a reminder that specific audience questions also surface.
We would prepare page briefs that pair approved facts with the questions buyers actually ask, starting with the pages already being cited. Each brief would note the audience, the approved claims and the evidence behind them. We would check existing coverage before proposing anything new, so effort goes to strengthening pages that already earn attention.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Nutrafol?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
Which is better, Nutrafol or Keeps? | 4 | 4 | 3 |
What is the best Hair Growth Accelerator? | 3 | 3 | 3 |
What is the best hair growth pill for men? | 3 | 3 | 3 |
What is the best hair regrowth company? | 3 | 3 | 3 |
What serum is good for hair growth? | 3 | 3 | 3 |
Which is better, Nutrafol or Rogaine? | 3 | 3 | 3 |
Is Rogaine better than Nutrafol? | 5 | 5 | 2 |
What is better, Nutrafol or Rogaine? | 3 | 3 | 2 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions are dominated by head-to-head comparisons, especially against Keeps and Rogaine, alongside broader prompts about the best hair growth pill or company. Nutrafol is mentioned in every one of these observed answers, which shows the brand is consistently in the frame when buyers ask. Recommendations are slightly less consistent in the Rogaine comparisons, where Nutrafol appears but is not always endorsed.
We would turn these observations into buyer-question content briefs, beginning with the comparison questions where the brand is already visible. Each brief would set out the question, the approved answer points and the evidence needed to support them. We would check whether existing pages already cover the question before commissioning new work, since these are recorded answer observations rather than verified demand.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Nutrafol work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month would establish the baseline scorecard, a scoped fact-review register and a shortlist of pages and sources to examine. Each record would carry an owner, an evidence requirement and a review status, so progress is visible without overstating what has been achieved. This groundwork keeps later work anchored to verified facts.
The second month would produce approved page briefs and any justified publisher requests, with confirmed edits, no-change decisions, requests and responses logged separately. The third month would add buyer-content briefs and a fresh scorecard. Throughout, completed work would be reported separately from measured answer outcomes, and no gain would be promised in advance.
Methodology
Questions This Section Answers
- How are Nutrafol answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 722 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 6305 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 722 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The figures describe how AI answers worded their responses in the captured sample, not customer satisfaction or sales. A company counts as recommended only when an answer endorses it with positive wording, and placement counts sit inside recommendations rather than adding to them. Answers can mention several brands, so company totals cannot be summed into a count of distinct answers.
The collection dates for the original answers have not been verified, and the current contents of cited pages still need independent checking. This edition uses a broader question set than earlier ones, so it is a new baseline rather than a continuation of past figures.
Our first three priorities
The first priority is to lock in the baseline and build the fact-review register, so the client has a reliable reference point and a clear process for handling claims. The second is to review the cited comparison pages directly and decide, page by page, whether anything is worth raising with a publisher. The third is to brief the owned pages already earning citations, pairing approved facts with the comparison questions buyers keep asking.
These three strands are connected: verification feeds the page briefs, and the briefs give the external review something concrete to align with. We would keep the work sequenced so nothing is requested or published before its evidence is confirmed, and we would report delivered work separately from any change in how answers treat Nutrafol.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending Hair Loss Treatments. For more detail, you can also read Hair Loss Treatments: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


